Acumapimod,
836683-15-9,
UNII-2F16KW647L,
BCT-197,
2F16KW647L,
3-(5-Amino-4-(3-cyanobenzoyl)pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide,
3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide,
Acumapimod [INN],
Acumapimod (BCT-197),
BCT197,
GTPL9203,
SCHEMBL1382253,
BCT 197,
VGUSQKZDZHAAEE-UHFFFAOYSA-N,
BCP29101,
EX-A1450,
compound A [WO2013139809],
AKOS032945000,
ZINC116024237,
CS-6195,
SB18669,
3-(5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide,
Benzamide, 3-(5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl)-N-cyclopropyl-4-methyl-,
HY-16715,
3-[5-amino-4-(3-cyano-benzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methyl-benzamide,
3-[5-Amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide,
CID11338127,
3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-N-cyclopropyl-4-methyl-benzamide,